StockSaints Logo 

STAAR Surgical Company $STAA Earnings For Wednesday Preview

STAAR Surgical Image

STAAR Surgical Company (STAA)

Background: Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.

Wall Street isn't expecting much this quarter. Earnings per share is expected to come in below last year for the same quarter. The earnings release is scheduled after the market closes on May 1, 2013.

The mean estimate is currently a break-even a share, a decline of 1 cent (100%) from 1 cent during the corresponding period last year. Analysts' estimates this quarter range from a break-even, to a high of 1 cent per share.
 

The short interest is slightly elevated, albeit, not yet enough to make me want to worry about it. As long as it stays under 4%, I won't give it much thought. Short interest is 3.8%, and if it starts to trend higher I recommend monitoring for a possible exit.
 

 

(STAA)

(NVS)

Strong Buy

1

2

Moderate Buy

2

0

Hold

3

3

Avg Analyst Price Target

$8.25

$73.94

Revenue

$69.89 million

$57.50 billion

Est High EPS

0.01

1.32

1 Year Stock Price Change

-39.47%

32.37%

 

Rate this article: 
Average: 5 (1 vote)
Stock Tickers: STAA NVS
STAAR Surgical Company
Tickers:

StockSaints Premium Options Newsletter block banner